Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

A ‘long road’ lies ahead for Regina boy, 4, after alleged medical malpractice

November 18, 2026

Flu cases have nearly doubled in 3 weeks. Is it too late to get your shot?

November 18, 2026

Tech lawsuits defined 2026 — and lawmakers want more

November 18, 2026

Old Navy and Gap face probe over ‘deceptive’ marketing claims in Canada

November 18, 2026

Ford puts onus on Ottawa ahead of Stellantis Brampton plant talks

November 18, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Neffy nasal spray for severe allergies now available without prescription
Health

Neffy nasal spray for severe allergies now available without prescription

By News RoomNovember 18, 20262 Mins Read
Neffy nasal spray for severe allergies now available without prescription
Share
Facebook Twitter LinkedIn Pinterest Email

Neffy, the epinephrine nasal spray for severe allergies, is now available without a prescription at pharmacies in Canada—but not for everyone.

The National Association of Pharmacy Regulatory Authorities (NAPRA) classified Neffy’s two milligram dose as a Schedule II product across Canada.

This means that the drug is now available without a prescription in provinces and territories where a prescription was previously required, ALK-Abelló Pharmaceuticals Inc. Canada said.

In April, Health Canada approved epinephrine nasal spray for use in adults and children with a body weight of 30 kilograms or 66 pounds for emergency treatment of severe allergic reactions, but it still needed classification from NAPRA.

Receive the latest medical news and health information delivered to you every Sunday.

Get weekly health news

Receive the latest medical news and health information delivered to you every Sunday.

The U.S. Food and Drug Administration approved the drug in the U.S. in 2024.

Allowing it to be sold behind the counter will give caregivers another way to carry and use epinephrine for first-line emergency treatment for severe allergic reactions, ALK Canada said.

Consumers will need to speak directly with the pharmacist who will conduct proper counselling before dispensing Neffy to patients without a prescription, the company added.

In 2024, results of four studies in 175 healthy adults, without anaphylaxis, showed Neffy worked about as well as injected epinephrine to boost heart rate and blood pressure, which counter severe reactions.


The two milligram dose of the Neffy nasal spray is equivalent to a 0.3 milligram dose in an epinephrine auto-injector, according to Food Allergy Canada.

The Neffy one milligram dose, which is not yet approved for use in Canada, can be used on patients weighing 15-30 kilograms. For now, the EpiPen Jr. with its 0.15 milligram dose, remains the only option for younger patients.

According to the FDA, some of the most common side effects of Neffy include throat irritation, tingling nose, headache, nasal discomfort, fatigue, runny nose, sneezing, abdominal pain, gum pain, numbness in the mouth, nasal congestion, dizziness, nausea and vomiting.

&copy 2026 Global News, a division of Corus Entertainment Inc.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Flu cases have nearly doubled in 3 weeks. Is it too late to get your shot?

Health Canada approves new Eli Lilly GLP-1 pill for weight loss

FDA to require vision loss warning on GLP-1 drug labels

Police investigate after 30 California marathon runners seek medical care

Intimate partner violence up 15% over 8 years in Canada, StatCan says

Stopping GLP-1 drugs could increase heart attack risk for some, study says

Beer recall hits 2 more Canadian products, bringing total to 31

U.S., Mexico both lose their measles elimination statuses: officials

GMA’s Gio Benitez shares ‘silent killer’ coronary artery disease diagnosis

Editors Picks

Flu cases have nearly doubled in 3 weeks. Is it too late to get your shot?

November 18, 2026

Tech lawsuits defined 2026 — and lawmakers want more

November 18, 2026

Old Navy and Gap face probe over ‘deceptive’ marketing claims in Canada

November 18, 2026

Ford puts onus on Ottawa ahead of Stellantis Brampton plant talks

November 18, 2026

Latest News

Banking outages are ‘a matter of when, not if.’ Do you know what to do?

November 18, 2026

Health Canada approves new Eli Lilly GLP-1 pill for weight loss

November 18, 2026

Avril Lavigne announces birth of 1st child: ‘Princess has arrived’

November 18, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version